ISRCTN88843062CompletedNot Applicable
STARRCAT: Surgical Timing After Radiotherapy for Rectal Cancer Analysis of Technique: a pilot randomised controlled trial
Yeovil District Hospital (UK)0 sites50 target enrollmentStarted: May 24, 2012Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 50
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •1. Age 18 years or over
- •2. Completing neo-adjuvant long-course
- •3. Chemoradiotherapy for rectal cancer
- •4. Fit for surgical resection by open or laparoscopic anterior resection or abdominoperineal excision (APE)
- •5. American Society of Anaesthesiology (ASA) grades I, II and III
- •6. Able and willing to provide written consent
- •7. Target Gender: Male & Female
Exclusion Criteria
- •1. Emergency admission or bowel obstruction/perforation
- •2. Short course radiotherapy regime
- •3. Anal cancer
- •4. Metastatic disease
- •5. Previous palliative pelvic radiotherapy
- •6. Rectal cancer on top of inflammatory bowel disease
- •7. Contra-indication to Magnetic Resonance Imaging scanning
- •8. Poor cognitive ability and/or unable to provide consent
- •9. Pregnancy
Investigators
Similar Trials
Withdrawn
Phase 2
Stereotactic ablative radiotherapy (SABR) after systemic antineoplastic treatment for patients with unresectable oligometastases (lung; liver; adrenal glands) from solid tumours: SARASTRO Trial (Stereotactic Ablative Radiotherapy After Systemic TReatment for Oligometastases) A randomised phase II trialmetastasesspread out cancer10027476NL-OMON37714niversitair Medisch Centrum Groningen80
Active, not recruiting
Phase 2
Stereotactic Radiotherapy for Oligoprogressive ER-positive Breast Cancer. AVATAR.Cancer - BreastER-positive, HER2-negative advanced breast cancerAdvanced breast cancerBreast CancerACTRN12620001212943Peter Mac Callum Cancer Centre32
Active, not recruiting
Not Applicable
Stereotactic accelerated radiotherapy concurrent with Temozolomide chemotherapy in newly diagnosed glioblastoma - NDglioblastoma of new diagnosisMedDRA version: 9.1Level: LLTClassification code 10018336EUCTR2009-015614-21-ITISTITUTO NEUROLOGICO CARLO BESTA
Active, not recruiting
Not Applicable
Preoperative chemotherapy and radiotherapy versus direct surgery in patients with pancreatic cancer: a multicentre studypatients with resectable or borderline resectable pancreatic cancer.EUCTR2012-003181-40-NLFoundation for Liverdisease244
Recruiting
Phase 3
Preoperative radiochemotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer: a multicentre randomized phase III clinical trial1001567410017991Pancreatic cancerNL-OMON45151Academisch Medisch Centrum244